Josephine Ford Cancer Center at Henry Ford Hospital

Summary

Josephine Ford Cancer Center at Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Brain Tumor, Central Nervous System Tumor, Glioblastoma and other specialties. Josephine Ford Cancer Center at Henry Ford Hospital is involved with conducting 175 clinical trials across 202 conditions. There are 9 research doctors associated with this hospital, such as Ding Wang, Shirish Gadgeel, MD, Tobias Walbert, MD, PhD, MPH, and Philip Kuriakose, MD.

Top PIs

Clinical Trials running at Josephine Ford Cancer Center at Henry Ford Hospital

Breast Cancer

Lung Cancer

Cancer

Acute Myeloid Leukemia

Leukemia

Acute Myelogenous Leukemia

Non-Small Cell Lung Cancer

Colorectal Cancer

Solid Tumors

Pancreatic Cancer

IAM1363

for Breast Cancer

This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.

Recruiting

1 award

Phase 1

MRT-2359

for Solid Tumors

This trial tests a new drug called MRT-2359 that breaks down a protein in cancer cells. It targets patients with certain types of previously treated cancers. The drug aims to destroy a protein crucial for cancer cell survival, potentially stopping or slowing the cancer.

Recruiting

1 award

Phase 1 & 2

7 criteria

Endoxifen

for Breast Cancer

This trial is testing (Z)-endoxifen, a drug that blocks estrogen, in pre-menopausal women with a specific type of breast cancer. The study aims to see if this drug can slow down cancer growth by measuring a marker called Ki-67. Participants will take the drug daily for several months before surgery.

Recruiting

1 award

Phase 2

7 criteria